Veterinary Intravenous (IV) Solutions Market to Grow with a CAGR of 6.57% through 2030F
Rising pet ownership and the increasing surge of
veterinary specialization are factors driving the global veterinary intravenous
(iv) solutions market in the forecast period 2026-2030F
According to TechSci Research report, “Veterinary
Intravenous (IV) Solutions Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Global
Veterinary Intravenous (IV) Solutions Market stood at USD 1.35 billion in 2024
and is anticipated to grow with a CAGR of 6.57% in the forecast period. Veterinary medicine has evolved from a generalized practice to a
field with specialized areas such as cardiology, oncology, and dermatology.
These specializations demand targeted treatments, including IV therapies, to
address specific health concerns. The development of specialized treatments has
expanded the market for veterinary IV solutions.
The livestock and production animal sectors play a critical
role in the global food supply. As demand for animal-based products continues
to rise, farmers and producers are recognizing the need for better healthcare
solutions to ensure the health and productivity of their animals. Veterinary IV
solutions are becoming essential tools in managing the health of livestock and
production animals. Just like humans, pets are also experiencing an increase in
life expectancy due to better healthcare practices and improved living
conditions. However, with age comes a higher likelihood of health issues that
require medical interventions, including IV therapies. The aging pet population
is contributing to the sustained demand for veterinary IV
solutions.
Rapid urbanization and changing lifestyles have led to smaller living spaces and limited outdoor access for pets. This often translates to increased health risks, making timely and effective medical interventions crucial. Veterinary IV solutions offer a reliable method of delivering medications and fluids to address various health conditions.
The phenomenon of pet humanization has taken the world by storm. As more households consider their pets as integral members of the family, the demand for advanced healthcare services has increased substantially. Pet owners are more willing to invest in treatments that ensure the health and well-being of their furry companions, including intravenous therapies.
Just as in human medicine, technological advancements are revolutionizing veterinary care. Newer and more efficient IV delivery systems, better monitoring tools, and improved diagnostic techniques are making IV solutions safer and more effective for animals. These technological innovations are driving the adoption of veterinary IV solutions across the globe.
Regulatory bodies across the globe are becoming more focused on ensuring the safety and efficacy of veterinary products, including IV solutions. This increasing scrutiny and regulation provide a conducive environment for the development and commercialization of high-quality veterinary IV solutions.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Veterinary Intravenous (IV) Solutions Market.”
The Global Veterinary Intravenous (IV) Solutions Market
is segmented into product, animal type, indication, end use and company.
Based on product, the isotonic crystalloids segment has
emerged as the predominant market leader. In the rapidly evolving landscape of
veterinary medicine, isotonic crystalloids have emerged as a dominant force in
the global veterinary IV solutions market. Their compatibility with physiology,
versatility, electrolyte-balancing capabilities, suitability for emergency
care, and minimal side effects position them as a trusted choice for
veterinarians worldwide. As the demand for advanced veterinary care continues
to rise, isotonic crystalloids are likely to maintain their stronghold in the
market, contributing significantly to the well-being and health of our beloved
animal companions. Isotonic crystalloids generally have few side effects,
making them safer for use in a variety of animal species. This safety profile
contributes to their popularity among veterinarians. In emergency situations,
quick fluid resuscitation is often essential to stabilize patients. Isotonic
crystalloids' ability to swiftly restore blood volume and circulatory stability
makes them a frontline choice in critical care scenarios.
Based on region, the Asia Pacific region is experiencing
rapid market growth. Apart from companion animals, Asia Pacific also holds a
substantial livestock industry. The increasing demand for safe and efficient
veterinary healthcare solutions in livestock production has contributed
significantly to the dominance of North America in the veterinary IV solutions
market. Farmers and ranchers prioritize animal health and invest in
high-quality medical interventions to ensure the productivity and welfare of their
livestock.
Major companies operating in Global Veterinary
Intravenous (IV) Solutions Market are:
· Merck
& Co., Inc.
· Dechra
Veterinary Products
· Sypharma
Pty Ltd.
· Animalcare
group plc
· Braun
SE
· Woods
Consulting, LLC
· Baxter
International
· Fresenius
Kabi
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“Veterinary IV solutions have revolutionized the way animals
receive medical care, providing essential fluids and medications with precision
and efficiency. The global trends in this field indicate a shift toward
specialization, technological integration, and nutritional support. While
challenges such as access and cost persist, the ongoing advancements and future
prospects paint a promising picture for the field of veterinary IV solutions.
As these innovations continue to evolve, the quality of care for animals around
the world is expected to improve, solidifying the crucial role of IV solutions
in the realm of veterinary medicine”, said Mr. Karan Chechi, Research Director
of TechSci Research, a research-based management consulting firm.
“Veterinary Intravenous (IV) Solutions Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By
Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose
solutions, Parenteral nutrition), By Indication (Diabetic Ketoacidosis,
Pancreatitis, Anthrax, Chronic Kidney Disease, Others), By Animal type (
Companion Animals, Production Animals), By End Use ( Veterinary Hospitals,
Research Institutes, Others), By Region &Competition, 2020-2030F”, has evaluated the future growth potential of
Global Veterinary Intravenous (IV) Solutions Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Veterinary Intravenous (IV) Solutions Market.
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602
Email: [email protected]
Website: https://www.techsciresearch.com